Innate immune responses following Kawasaki disease and toxic shock syndrome-Reference-Cited by-同舟云学术

Innate immune responses following Kawasaki disease and toxic shock syndrome

Published:2018-02-15 Issue:2 Volume:13 Page:e0191830
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Chen Katherine Y. H.^ORCID,Messina Nicole,Germano Susie,Bonnici Rhian,Freyne Bridget,Cheung Michael,Goldsmith Greta,Kollmann Tobias R.,Levin Michael,Burgner David,Curtis Nigel

Funder

University of Melbourne

Murdoch Childrens Research Institute

National Health and Medical Research Council

Jam and Jelly Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference40 articles.

1. A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan;T Kawasaki;Pediatrics,1974

2. Kawasaki Disease;JW Newburger;J Am Coll Cardiol,2016

3. Epidemiologic features of Kawasaki disease in Japan: Results of the 2009–2010 nationwide survey;Y Nakamura;J Epidemiol,2012

4. Epidemiology of Kawasaki disease in Asia, Europe, and the United States;R Uehara;J Epidemiol,2012

5. Kawasaki Disease in Families;Y Fujita;Pediatrics,1989

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between FGA gene polymorphisms and coronary artery lesion in Kawasaki disease;Frontiers in Medicine;2023-07-27

2. Potential roles of NLRP3 inflammasome in the pathogenesis of Kawasaki disease;Journal of Cellular Physiology;2023-01-17

3. Identifying differentially expressed genes and miRNAs in Kawasaki disease by bioinformatics analysis;Scientific Reports;2022-12-19

4. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral NLRP3 Inflammasome Inhibitor ZYIL1: First‐in‐Human Phase 1 Studies (Single Ascending Dose and Multiple Ascending Dose);Clinical Pharmacology in Drug Development;2022-09-05

5. Pathogenic and therapeutic roles of cytokines in Kawasaki diseases;Clinica Chimica Acta;2022-07